Corient Private Wealth’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Buy
+8,255
New +$385K ﹤0.01% 2227
2024
Q4
Sell
-3,430
Closed -$237K 2380
2024
Q3
$237K Sell
3,430
-310
-8% -$20K ﹤0.01% 2135
2024
Q2
$239K Sell
3,740
-155
-4% -$11.7K ﹤0.01% 2029
2024
Q1
$366K Buy
3,895
+42
+1% +$3.38K ﹤0.01% 1787
2023
Q4
$283K Buy
3,853
+419
+12% +$26.8K ﹤0.01% 1888
2023
Q3
$215K Sell
3,434
-321
-9% -$21.6K ﹤0.01% 1886
2023
Q2
$278K Buy
3,755
+489
+15% +$37.3K ﹤0.01% 1737
2023
Q1
$257K Buy
3,266
+72
+2% +$5.2K ﹤0.01% 1677
2022
Q4
$218K Buy
+3,194
New +$203K ﹤0.01% 1459

Other funds holding BRKR

Corient Private Wealth's BRKR Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Bruker (BRKR) in Q2 2026: 8,255 shares worth $497K. The stake represents ﹤0.01% of the portfolio and ranks #2227 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in BRKR as recently as Q3 2024.

Corient Private Wealth first reported a position in BRKR in Q4 2022 and has held it in 9 quarters since. 417 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Corient Private Wealth held 8,255 shares of Bruker worth $497K as of Q2 2026.
  • Bruker was a new Corient Private Wealth position in Q2 2026.
  • Bruker made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2227 holding.
  • Corient Private Wealth first reported a position in Bruker in Q4 2022 and has held it in 9 quarters since.
  • 417 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.